A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/20/2011	WO2011128374A1 Insulin-sirna conjugates
10/20/2011	WO2011128364A1 Acetaminophen composition
10/20/2011	WO2011128230A1 Effervescent pharmaceutical compositions containing n-acetylcysteine
10/20/2011	WO2011127989A1 Nicotine conjugate vaccine
10/20/2011	WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	WO2011127532A1 Tethered matrix metalloproteinase inhibitor
10/20/2011	WO2011100131A9 Monomers and oligonucleotides comprising cycloaddition adduct(s)
10/20/2011	WO2011072218A3 Stable formulations for lyophilizing therapeutic particles
10/20/2011	WO2011070318A3 Topical formulation
10/20/2011	WO2011069076A3 Sustained release donepezil formulations
10/20/2011	WO2011059198A3 Pharmaceutical composition containing a bisphosphonate
10/20/2011	WO2011039259A3 Mucoadhesive polymers having vitamin b partial structures
10/20/2011	WO2011036357A3 Stable, liquid, ready-to-use ketoprofen formulation
10/20/2011	WO2011006504A3 Treatment of hyperproliferative conditions
10/20/2011	US20110257628 Instrument for alleviating addictive drug craving, method for using same and method for treating addictive drug dependence
10/20/2011	US20110257504 Biologically integrated electrode devices
10/20/2011	US20110257272 Mixed crystals, method for the production thereof and use thereof in the production of baked goods
10/20/2011	US20110257259 Nut skin products and methods of use thereof
10/20/2011	US20110257253 Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
10/20/2011	US20110257249 Drug carriers
10/20/2011	US20110257141 Transdermal pharmaceutical formulation for minimizing skin residues
10/20/2011	US20110257132 Charged phospholipid compositions and methods for their use
10/20/2011	US20110257106 Polymer Stabilized Neuropeptides
10/20/2011	US20110257015 Polymers, compositions and methods for use for foams, laundry detergents, shower rinses and coagulants
10/20/2011	US20110256224 Methods and compositions for targeted delivery
10/20/2011	US20110256223 Gastric retained gabapentin dosage form
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256201 Hydrolyzed hydrogels
10/20/2011	US20110256193 Use Of Copolymers Based On Polyethers And Vinyl Monomers As Stabilizing Agents For Emulsions
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256095 Tissue Matrix System
10/20/2011	US20110256089 Hydrogel Type Cell Delivery Vehicle for Wound Healing, and Preparation Method Thereof
10/20/2011	US20110253633 Catanionic vesicles, process for preparing same and applications thereof
10/20/2011	CA2799550A1 Stabilized statin formulations
10/20/2011	CA2796334A1 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
10/20/2011	CA2796215A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	CA2796197A1 Compositions comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists
10/20/2011	CA2796168A1 Acetaminophen composition
10/20/2011	CA2796077A1 Compounds, compositions, and methods for reducing or eliminating bitter taste
10/20/2011	CA2796072A1 Compounds, compositions, and methods for reducing or eliminating bitter taste
10/20/2011	CA2795908A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same
10/20/2011	CA2795723A1 Method and ophthalmic composition for treating retinal disease
10/20/2011	CA2795360A1 Tissue targeting
10/20/2011	CA2795349A1 Targeted pyrrolobenzodiazepine conjugates
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	CA2793890A1 Pyrrolobenzodiazepines and conjugates thereof
10/19/2011	EP2377926A1 Chondrocyte-like cell, and method for producing same
10/19/2011	EP2377558A2 Composition for improving inflammatory disease using abh antigens
10/19/2011	EP2377557A2 Compositions comprising azelastine and methods of use thereof
10/19/2011	EP2377556A1 A compound
10/19/2011	EP2377545A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
10/19/2011	EP2377540A1 Transdermal patch containing 17-deacetyl norgestimate
10/19/2011	EP2377538A1 Aqueous oral preparation of stable amlodipine
10/19/2011	EP2377535A1 Method and composition for treating multiple sclerosis (variants)
10/19/2011	EP2377524A1 Method of stabilizing reduced coenzyme Q10
10/19/2011	EP2377520A1 Pharmaceutical compound of prasugrel
10/19/2011	EP2377519A2 Pharmaceutical Composition Comprising Octreotide Microparticles
10/19/2011	EP2377516A1 Acetaminophen composition
10/19/2011	EP2377514A2 Liquid parenteral formulation comprising a tramadol material and paracetamol
10/19/2011	EP2376123A2 Oligosaccharide-protein conjugates
10/19/2011	EP2376098A1 Dipeptide linked medicinal agents
10/19/2011	EP2376096A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
10/19/2011	EP2376075A2 Nasal formulations of metoclopramide
10/19/2011	EP2376071A2 Method for preparing microspheres and microspheres produced thereby
10/19/2011	EP2376069A2 Microparticles comprising adipose stem cells
10/19/2011	EP2376067A2 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
10/19/2011	EP2376063A1 Novel form of administering osteogenic protein complexes
10/19/2011	EP2376060A2 Nanoparticle compositions
10/19/2011	EP2376058A1 Drug delivery devices for delivery of therapeutic agents
10/19/2011	EP2375905A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control
10/19/2011	EP2187767B1 Increased creatine retention with soluble fibres
10/19/2011	EP1782816B1 Water-based medicinal composition containing azithromycin and method of preparing the same
10/19/2011	EP1687024B1 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
10/19/2011	EP1595936B1 Composition for external use
10/19/2011	EP1572918B1 Synthetic glyco-lipo-peptides as vaccines
10/19/2011	EP1513506B1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1341524B1 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
10/19/2011	EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
10/19/2011	EP1139974B1 Soy depigmenting and skin care compositions
10/19/2011	CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/19/2011	CN1980671B Liposome preparation containing slightly water-soluble camptothecin
10/19/2011	CN1706385B New composition for treating seasonal and perennial allergic rhinitis
10/19/2011	CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease
10/19/2011	CN102223898A Peptides for treatment of obesity
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102223881A Fast dissolving oral tablets and method for production thereof
10/19/2011	CN102223880A Orally rapidly disintegrating tablet, and process for producing same
10/19/2011	CN102223875A Pharmaceutical composition of a potent hcv inhibitor for oral administration
10/19/2011	CN102220298A Ferulic acid esterase FaeI as well as coding gene and application thereof
10/19/2011	CN102220256A Yeast expression system for expressing HAS-Vmip-II fusion protein and construction method thereof
10/19/2011	CN102220017A Injectable moulded silk fibroin hydrogel and preparation method thereof
10/19/2011	CN102219986A Biodegradable poly(butylene adipate/terephthalate) hollow foamed particle and preparation method thereof
10/19/2011	CN102219938A Preparation method of hydrophobically modified sodium alginate
10/19/2011	CN102219912A Preparation method for granular type xanthan gum

1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 1712